Phage therapy is emerging as a potential solution to antibiotic resistance and superbugs, with clinical advances in ...

This article explains why soil remains a vital source of new antibiotics, showing how modern tools are reviving discovery ...

The EU has pledged €30 million ($35 million) in funding for medical countermeasures to antimicrobial resistance (AMR), ...

It’s more than skin-deep.

Recce is developing a new class of antibiotics to tackle drug-resistant superbugs almost a century after the development of ...

ESCMID is the premier annual congress of the European Society of Clinical Microbiology and Infectious Diseases. It takes place from April 17 - 21, 2026 in Munich, Germany.

AI dramatically expands the chemical universe scientists can explore. This is particularly important in antibiotic discovery, ...

By Milliam MurigiThe European Commission has committed more than $100 million to tackle antimicrobial resistance (AMR) in Africa.The funding includes $50 million to strengthen Africa–Europe health ...

Every caesarean section, joint replacement, and round of chemotherapy depends on effective antibiotics. In medicine as in war ...

Phage therapies present growth opportunities by leveraging their specificity against antibiotic-resistant bacteria, offering customizable treatments with minimal microbiome disruption. Key areas ...

Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, intends to present a full suite of preclinical findings from the company’s lead candidate, ...